Compass Nears Psilocybin Filing
I denne episoden
- Compass Nears Psilocybin Filing
- Novartis Ends BioArctic Pact
- Sun Pharma Halts Eye Production
- Qureight Pushes Fibrosis Endpoint
Kilder
- BioSpace: Compass to submit psilocybin depression drug for approval imminently after stock wobbles
- BioSpace: Novartis puts $772M BioArctic deal on ice, skates away from brain-delivery alliance
- BioSpace: Sun Pharma stops eye-care drug production at Indian plant amid quality issues
- Pharmatimes: Qureight calls for fibrosis burden to lead imaging biomarkers
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.